MannKind Corporation, headquartered in Valencia, CA, announced at the American Chemical Society Spring 2010 National Meeting that its first product, Afrezza, an inhalable form of mealtime insulin, is awaiting approval...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)